Enzyme News and Research

RSS
A ferritin nanoparticle candidate vaccine for COVID

A ferritin nanoparticle candidate vaccine for COVID

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

The different actions of CBD in SARS-CoV-2 infection

The different actions of CBD in SARS-CoV-2 infection

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Study investigates SARS-CoV-2 infection in Swiss stray cats

Study investigates SARS-CoV-2 infection in Swiss stray cats

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

New compound delivered in a nasal spray effectively treats delta variant infection in mice

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Japanese researchers discover new mechanisms of action by extracellular vesicles in lymphoma

Japanese researchers discover new mechanisms of action by extracellular vesicles in lymphoma

Chaperone-mediated autophagy needed to protect against atherosclerosis

Chaperone-mediated autophagy needed to protect against atherosclerosis

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

Researchers discover new pathway for DNA transfer in tumor microenvironment

Researchers discover new pathway for DNA transfer in tumor microenvironment

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study explores macrophage susceptibility to SARS-CoV-2 virions

Study explores macrophage susceptibility to SARS-CoV-2 virions

Topologically designed antibody candidates for SARS-CoV-2 and cancer therapies

Topologically designed antibody candidates for SARS-CoV-2 and cancer therapies

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.